Impact of bioresorbable versus permanent polymer on long-term vessel wall inflammation and healing: a comparative drug-eluting stent experimental study

EuroIntervention 2018;13:1670-1679 published online August 2017. DOI: 10.4244/EIJ-D-17-00332

Gregory J. Wilson
Gregory J. Wilson1, MD; Jennifer McGregor2, BS; Gerard Conditt2, RCIS; Masahiko Shibuya2, MD; Natalia Sushkova3, MD; Michael J. Eppihimer3, PhD; Steven P. Hawley1, MSc; Serge D. Rousselle4, DVM; Barbara A. Huibregtse3, DVM; Keith D. Dawkins3, MD; Juan F. Granada2*, MD
1. Division of Pathology, Department of Paediatric Laboratory Medicine, Hospital for Sick Children, Toronto, ON, Canada; 2. Skirball Center for Innovation, Cardiovascular Research Foundation, Orangeburg, NY, USA; 3. Boston Scientific Corporation, Marlboro

Aims: Drug-eluting stents (DES) have evolved to using bioresorbable polymers as a method of drug delivery. The impact of bioresorbable polymer on long-term neointimal formation, inflammat

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

clinical researchpreclinical researchstent enhancement
Read next article
Comparison of the prognostic value of non-ischaemic fractional flow reserve using intracoronary versus intravenous adenosine

Latest news